Annual Drug Patent Expirations for LOREEV+XR
Loreev Xr is a drug marketed by Almatica and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
This drug has twenty-nine patent family members in twenty-nine countries.
The generic ingredient in LOREEV XR is lorazepam. One supplier is listed for this compound. Additional details are available on the lorazepam profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com